BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37700453)

  • 1. Association between cognitive impairment and olfactory deficits in systemic lupus erythematosus without major neuropsychiatric syndromes.
    Xu X; Kong W; Geng L; Chen C; Yang H; Bian W; Chen S; Xu R; Liang J; Sun L
    Lupus; 2023 Oct; 32(11):1245-1257. PubMed ID: 37700453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    Ceccarelli F; Pirone C; Mina C; Mascolo A; Perricone C; Massaro L; Spinelli FR; Alessandri C; Valesini G; Conti F
    PLoS One; 2019; 14(11):e0224437. PubMed ID: 31682630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction in patients with systemic lupus erythematosus. A cross-sectional study in a Brazilian sample.
    Borba EA; Scoto Dias E; Tercziany Vanzin JH; Ferreira de Queiroz Junior N; Dos Santos TAF; Skare T; Nisihara R
    Lupus; 2023 Jun; 32(7):900-909. PubMed ID: 37204123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical associations of cognitive dysfunction in systemic lupus erythematosus.
    Raghunath S; Glikmann-Johnston Y; Golder V; Kandane-Rathnayake R; Morand EF; Stout JC; Hoi A
    Lupus Sci Med; 2023 Feb; 10(1):. PubMed ID: 36854540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Performance in Patients with Systemic Lupus Erythematosus Using the Ped-ANAM.
    de Amorim JC; Sepresse SR; Vivaldo JF; Julio PR; Kishimoto ST; Marini R; Fernandes PT; Costallat LTL; Appenzeller S
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
    Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
    J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
    Morrison E; Carpentier S; Shaw E; Doucette S; Hanly JG
    Lupus; 2014 Apr; 23(4):370-7. PubMed ID: 24457602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of damage accrual in systemic lupus erythematosus: a longitudinal observational study with focus on neuropsychological factors and anti-neuronal antibodies.
    Mimica M; Barra I; Ormeño R; Flores P; Calderón J; Padilla O; Bravo-Zehnder M; González A; Massardo L
    Clin Rheumatol; 2019 Nov; 38(11):3129-3137. PubMed ID: 31367942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    Kim SK; Choe JY; Lee SS
    J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
    Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
    Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
    Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
    Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
    Urowitz MB; Gladman DD; Ibañez D; Fortin PR; Bae SC; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Sanchez-Guerrero J; Wallace DJ; Ginzler E; Alarcón GS; Merrill JT; Bruce IN; Sturfelt G; Nived O; Steinsson K; Khamashta M; Petri M; Manzi S; Ramsey-Goldman R; Dooley MA; van Vollenhoven RF; Ramos M; Stoll T; Zoma A; Kalunian K; Aranow C
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):132-7. PubMed ID: 21954226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Goldsmith CH; Fortin P; Ginzler E; Gordon C; Hanly JG; Isenberg DA; Kalunian K; Nived O; Petri M; Sanchez-Guerrero J; Snaith M; Sturfelt G
    Arthritis Rheum; 1997 May; 40(5):809-13. PubMed ID: 9153540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum BDNF and cognitive dysfunction in SLE: findings from a cohort of 111 patients.
    Alessi H; Dutra LA; Maria LA; Coube PC; Hoshino K; de Abrantes FF; Lopes FC; de Souza AWS; Kayser C; Barsottini OGP
    Clin Rheumatol; 2022 Feb; 41(2):421-428. PubMed ID: 34537904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive dysfunction in systemic lupus erythematosus in relation to disease activity and damage].
    Dorman G; Micelli M; Cosentino V; Ottone L; Nuñez MR; Mangone C; Rey RC; Kerzberg E; Genovese O
    Medicina (B Aires); 2017; 77(4):257-260. PubMed ID: 28825566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cognitive impairment in SLE using the Self-Administered Gerocognitive Exam.
    Meara A; Davidson N; Steigelman H; Zhao S; Brock G; Jarjour WN; Rovin BH; Madhoun H; Parikh S; Hebert L; Ayoub I; Ardoin SP
    Lupus; 2018 Jul; 27(8):1363-1367. PubMed ID: 29466913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.